Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 168

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The l-arginine—nitric oxide pathway: role in atherosclerosis and therapeutic implications

Open access
Böger, Rainer H., Bode-Böger, Stefanie M., Frölich, Jürgen C. · 1996 · Atherosclerosis

Abstract

1. Biochemistry of the L-arginine-NO pathway The endothelium plays a crucial role in the vasodila- tor response to a large variety of drugs. In 1980 Furchgott and co-workers had discovered that the pres- ence of an intact endothelium is mandatory for the relaxation of isolated blood vessels by acetylcholine in vitro, whereas acetylcholine induced contractions in arterial preparations in which the endothelium had been injured or mechanically removed [l]. It was soon discovered that endothelial cells release an unknown soluble relaxing factor, which was named endothelium derived relaxing factor [2], and which in 1987 was shown to be virtually identical with nitric oxide (NO) [3], in response to a variety of pharmacological and physiological stimuli (Fig. 1). Subsequently the amino acid L-arginine was iden- tified as the biological precursor of NO [4]. NO acti- vates vascular smooth muscle soluble guanylate cyclase, increasing cyclic GMP and decreasing intracellular Ca2+ concentrations, among other effects [5]. Cyclic GMP as the second messenger mediates many of the biological effects of NO, among which are-in the cardiovascular system-relaxation of smooth muscle and inhibition of platelet aggregation [5]. The enzyme converting L-arginine to NO was purified and cloned in 1991 [6,7], and was named nitric oxide synthase (NOS).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0021-9150(96)05953-9

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 168

Metadata

Authors
Böger, R. H., Bode-Böger, S. M., & Frölich, J. C.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
1996-11
Volume
127
Issue
1
Pages
1-11
ISSN
0021-9150 (ISSN-L)
OpenAlex
W2071654814
Cited by
168
References
6
FWCI
7.13
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The l-arginine—nitric oxide pathway: role in atherosclerosis and therapeutic implications. https://app.cochat.ai/papers/10.1016/s0021-9150(96)05953-9
The paper
Böger, R. H., Bode-Böger, S. M., & Frölich, J. C. (1996). The l-arginine—nitric oxide pathway: role in atherosclerosis and therapeutic implications. Atherosclerosis. https://doi.org/10.1016/s0021-9150(96)05953-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.